TMTaha Mbbs Mehmood

Taha Mbbs Mehmood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Taha Mbbs Mehmood has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mortality among U.S. adults with coexisting type 2 diabetes mellitus and malignant neoplasms: A nationwide observational study (1999–2024)

    by Muhammad Husnain Ahmad, Masab Ali, Muhammad Hassan, Muhammad Abdullah, Moiz Ul Haq Hashmi, Amina Jamil, Taha Mehmood, Abdullah Zaheer, Ahmad Zia, Muhammad Umar Shahid, et al.

    Type 2 diabetes mellitus (T2DM) and malignant neoplasms are among the most prevalent chronic diseases worldwide. When coexisting, they substantially increase morbidity and mortality. However, national trends in mortality among patients with coexisting T2DM and malignant neoplasms in the United States remain underexplored. We analyzed U.S. death certificates from the CDC WONDER database for individuals aged ≥ 25 years who died between 1999 and 2024 with both T2DM and malignant neoplasms listed anywhere on the death certificate (underlying or contributing causes). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status. From 1999 to 2024, 357,910 U.S. deaths occurred among individuals in whom both Type 2 Diabetes Mellitus and Malignant Neoplasms were listed on the death certificate. The AAMR rose from 6.37 to 17.2 per 100,000, with an overall APC of + 3.84%. Men exhibited higher mortality than women. Older adults bore the greatest burden, though middle-aged adults also showed a sharp proportional rise. Hispanic and Asian populations experienced the steepest increases. The West region showed the most pronounced growth. State-level variation exceeded fivefold, with Nebraska reporting the highest AAMR and Nevada the lowest. nonmetropolitan areas maintained higher mortality throughout, but metropolitan areas demonstrated a steeper rise, narrowing the rural–urban gap. Mortality among individuals with coexisting T2DM and malignant neoplasms has risen substantially in the U.S., with disproportionate increases among men, minority populations, and urban residents. These findings highlight the urgent need for integrated strategies addressing diabetes control, cancer prevention, and health equity across demographic and geographic subgroups.

  • Open Access

    Trends in urinary tract infection–related mortality among older adults with dementia in the United States: A population-based observational study using CDC WONDER (1999–2020)

    by Aasim Mbbs Ali, Masab Mbbs Ali, Muhammad Mbbs Abdullah, Muhammad Mbbs Hassan, Taha Mbbs Mehmood, Muhammad Husnain Mbbs Ahmad, Waqar Ahmed Mbbs Cheema, Muhammad Mujtaba Mbbs Tariq, Ahmad Mbbs Zia, Muhammad Mbbs Asadullah, et al.

    Dementia is a major cause of morbidity and mortality among older adults, and urinary tract infections (UTIs) are frequent, clinically significant complications in this population. However, there is limited national evidence describing mortality trends where UTI is listed as the underlying cause of death among individuals with dementia in the United States. We conducted a population-based descriptive study using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause-of-Death database (1999–2020). Deaths were identified using International Classification of Diseases, 10th Revision codes for UTI (N39.0) as the underlying cause and unspecified dementia (F03) as a multiple cause. We computed crude and age-adjusted mortality rates (AAMR) per 100,000, standardized to the 2000 US population. Temporal trends were assessed using joinpoint regression to estimate annual percent change and 95% confidence intervals (CIs), stratified by sex, age, race/ethnicity, region, and urbanization. Between 1999 and 2020, 125,797 deaths were attributed to UTI with comorbid unspecified dementia. The national AAMR increased from 18.20 to 26.30 per 100,000, with a non-significant annual percent change (−0.44%, 95% confidence interval = −1.38 to 0.51), suggesting no consistent annual increase. Mortality increased similarly in both sexes, but the absolute burden was higher in women. The highest mortality occurred among adults aged ≥75 years. Non-Hispanic White individuals accounted for most deaths and showed a 51.1% increase in AAMR. The greatest state-level rates were observed in South Carolina, North Carolina, West Virginia, Oklahoma, and Tennessee, while the lowest were in Arizona, Nevada, and Hawaii. Nonmetropolitan areas consistently experienced higher mortality. Mortality due to UTI as the underlying cause of death among older adults with dementia remained stable in the United States from 1999 to 2020, with notable geographic and demographic disparities. Women, non-Hispanic Whites, older adults, and rural residents carried the highest burden. These findings highlight the urgent need for improved infection prevention, timely diagnosis of atypical UTI presentations, and equitable access to healthcare for dementia patients, particularly in high-risk and rural regions.